Athrombin-k

   
Google
 
Web NewDrugInformation.com

Athrombin-k


Drug - Athrombin-k
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Warfarin Potassium
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Warfarin Potassium. May repeat for multiple part products.

Applicant - PURDUE FREDERICK
The firm name holding legal responsibility for Athrombin-k. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011771
The FDA assigned number to Athrombin-k. Format is nnnnnn.

Product Number - 005
The FDA assigned number to identify Athrombin-k. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Athrombin-k was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Athrombin-k. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Athrombin-k is in. Format is RX, OTC, DISCN.

Applicant Full Name - Purdue Frederick Co
The full name of the firm holding legal responsibility for the new application of Athrombin-k.

Athrombin-k